Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada flag Canada · Delayed Price · Currency is CAD
0.155
-0.005 (-3.13%)
Dec 5, 2025, 9:30 AM EST
-35.42%
Market Cap 21.35M
Revenue (ttm) 2.63M
Net Income (ttm) -4.60M
Shares Out 133.46M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,450
Average Volume 24,514
Open 0.155
Previous Close 0.160
Day's Range 0.155 - 0.155
52-Week Range 0.130 - 0.290
Beta -0.70
RSI 47.88
Earnings Date Jan 29, 2026

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provis... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mark Upsdell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DOSE
Full Company Profile

Financial Performance

In 2024, Rapid Dose Therapeutics's revenue was 2.09 million, an increase of 104.34% compared to the previous year's 1.02 million. Losses were -5.40 million, 25.5% more than in 2023.

Financial Statements

News

There is no news available yet.